Compare VVOS & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | COSM |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.4M | 18.9M |
| IPO Year | 2020 | 2009 |
| Metric | VVOS | COSM |
|---|---|---|
| Price | $1.62 | $0.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | 124.1K | ★ 788.8K |
| Earning Date | 02-23-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.07 | 45.58 |
| EPS | N/A | ★ N/A |
| Revenue | $15,031,000.00 | ★ $54,426,402.00 |
| Revenue This Year | $28.86 | $20.69 |
| Revenue Next Year | $48.70 | $53.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.91 | 1.97 |
| 52 Week Low | $1.42 | $0.28 |
| 52 Week High | $7.40 | $1.32 |
| Indicator | VVOS | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 44.03 | 35.25 |
| Support Level | $1.46 | $0.35 |
| Resistance Level | $1.67 | $0.43 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 45.24 | 17.05 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.